DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR THE CONCURRENT QUANTIFICATION OF SUMATRIPTAN AND NAPROXEN IN PHARMACEUTICAL DOSAGE FORM. LEX. 2025;23(S6):5043-5051. doi:10.52152/yqpzpf81